Menu Back toSESSION 2 : Minimum Consensus Package – Essence of Quality and Nonclinical Safety Parts

5th DIA Cell and Gene Therapy Products Symposium in Japan

This event is now offered in a new entirely virtual format.

All prices are exclusive of 10% Japanese consumption tax

SESSION 2 : Minimum Consensus Package – Essence of Quality and Nonclinical Safety Parts

Session Chair(s)

Daisaku  Sato, PhD, MPharm, RPh

Daisaku Sato, PhD, MPharm, RPh

  • Director, Compliance & Narcotics Division
  • Ministry of Health, Labour and Welfare, Japan
Yoji  Sato, PhD

Yoji Sato, PhD

  • Head, Division of Cell-Based Therapeutic Products
  • National Institute of Health Sciences, Japan

Speaker(s)

Satoshi  Yasuda, PhD

Overview of Minimum Consensus Package

Satoshi Yasuda, PhD

  • Chief, Division of Cell-Based Therapeutic Products
  • National Institute of Health Sciences, Japan
Takashi  Aoi, MD, PhD

Case Study 1:Cell Bank, Cell Characterization

Takashi Aoi, MD, PhD

  • Professor, Center for iPS cell research and application (CiRA)
  • Kyoto University, Japan
Akifumi  Matsuyama, PhD

Nonclinical Testing in MCP

Akifumi Matsuyama, PhD

  • Osaka Habikino Medical Center, Osaka Prefectural Hospital Organization, Japan

Contact us


Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574